Stock Earnings

Question 1

What are TriSalus Life Sciences Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), TriSalus Life Sciences Inc has a total asset of $24, Net loss of $-33

Question 2

What are the key financial ratios for TLSI?

Accepted Answer

TriSalus Life Sciences Inc's Current ratio is 0.48, has a Net margin is -113.79, sales per share of $1.16.

Question 3

How is TriSalus Life Sciences Inc's revenue broken down by segment or geography?

Accepted Answer

TriSalus Life Sciences Inc largest revenue segment is Innovative Drug Delivery Technology and Immune-oncology Therapeutics, at a revenue of 18,511,000 in the most earnings release.For geography, United States is the primary market for TriSalus Life Sciences Inc, at a revenue of 18,511,000.

Question 4

Is TriSalus Life Sciences Inc profitable?

Accepted Answer

no, according to the latest financial statements, TriSalus Life Sciences Inc has a net loss of $-33

Question 5

Does TriSalus Life Sciences Inc have any liabilities?

Accepted Answer

yes, TriSalus Life Sciences Inc has liability of 50

Question 6

How many outstanding shares for TriSalus Life Sciences Inc?

Accepted Answer

TriSalus Life Sciences Inc has a total outstanding shares of 31

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	35	29	18	0	0	0
Revenue Growth (YoY)	13%	61%	--	--	--	--
Cost of Revenue	5	4	2	--	--	--
Gross Profit	30	25	15	--	--	--
Selling, General & Admin	48	44	41	2	3	0
Research & Development	14	17	29	--	--	--
Operating Expenses	61	61	70	2	3	0
Other Non Operating Income (Expenses)	4	8	0	5	7	0
Pretax Income	-30	-30	-59	6	4	0
Income Tax Expense	0	0	0	0	--	--
Net Income	-34	-33	-64	5	4	0
Net Income Growth	-40%	-48%	-1,380%	25%	--	--
Shares Outstanding (Diluted)	33	25	9.4	29.61	31.25	30.56
Shares Change (YoY)	38%	166%	-68%	-5%	2%	--
EPS (Diluted)	-1.03	-1.31	-6.8	0.19	0.15	-0.02
EPS Growth	-56.99%	-81%	-3,679%	27%	-850%	--
Free Cash Flow	-29	-41	-51	-2	-1	0
Free Cash Flow Per Share	-0.87	-1.64	-5.42	-0.06	-0.03	0
Gross Margin	85.71%	86.2%	83.33%	--	--	--
Operating Margin	-85.71%	-124.13%	-300%	0%	0%	0%
Profit Margin	-97.14%	-113.79%	-355.55%	0%	0%	0%
Free Cash Flow Margin	-82.85%	-141.37%	-283.33%	0%	0%	0%
EBITDA	-30	-36	-54	--	--	--
EBITDA Margin	-85.71%	-124.13%	-300%	--	--	--
D&A For EBITDA	0	0	0	--	--	--
EBIT	-30	-36	-54	-2	-3	0
EBIT Margin	-85.71%	-124.13%	-300%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	--	--

TriSalus Life Sciences Inc (TLSI) Price

TLSI Stock Price Chart

TLSI Income

Follow-Up Questions